Quantinuum Inc. (NASDAQ:QNT – Get Free Report) Director Hal Barron bought 250,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The shares were acquired at an average price of $60.00 per share, with a total value of $15,000,000.00. Following the completion of the transaction, the director owned 255,833 shares of the company’s stock, valued at approximately $15,349,980. The trade was a 4,285.96% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Quantinuum Stock Performance
NASDAQ:QNT opened at $58.40 on Tuesday. Quantinuum Inc. has a twelve month low of $51.15 and a twelve month high of $71.35.
Key Stories Impacting Quantinuum
Here are the key news stories impacting Quantinuum this week:
- Positive Sentiment: Director Hal Barron made the largest purchase, buying 250,000 shares for $15.0 million, a sizable increase in his ownership that stands out as a strong insider confidence signal. SEC filing for Hal Barron purchase
- Positive Sentiment: Multiple other directors also bought shares at $60 each, including Joseph Jimenez, who purchased 66,665 shares, and Manish H. Bhatia, Kenneth D. Denman, and others, reinforcing the bullish insider signal. SEC filing for Joseph Jimenez purchase
- Positive Sentiment: CFO Nitesh Sharan also added to his stake, which can help reassure investors that leadership remains aligned with shareholders. SEC filing for Nitesh Sharan purchase
- Neutral Sentiment: One article also highlighted a bullish opinion piece, “Quantinuum: Buying Apollo Today,” but it appears to be commentary rather than a new fundamental development. Seeking Alpha article
See Also
- Five stocks we like better than Quantinuum
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.
